ETF Factsheet · Health

iShares U.S. Healthcare ETF (IYH)

IYH ETF fact sheet: fees, assets under management, composition, allocation and performance, based on the positions published by the issuer.

Theme HealthIssuer ISharesClass EquityDomicile United StatesPEA no (fund domiciled outside Europe)
Symbol IYH·ISIN US4642877629·Created on 2000-06-12·Positions at 2026-11-08·Sheet of the 14/11/2026
Annual fees
0,37 %
deducted from the share value
Outstanding
4,73 $bn
in US dollars
Number of lines
103
published positions
Weight of the top 10
59,0 %
concentration
Performance 1 year
+22,9 %
price in USD
3 year performance
+49,1 %
i.e. +14,2 % per year
5 year performance
+36,7 %
i.e. +6,5 % per year
Volatilité 1 an
16,9 %
annualized standard deviation
Worst drop
-18,7 %
from a high, 5 years
Last share price
78,95 USD
+0,42 % during the session
Reading. Fees of 0,37 % per year represent 37 € deducted each year for every € 10 000 invested, directly in the share value. Healthcare ETFs mix pharmaceuticals, medical equipment, and biotechnologies: a defensive sector in the United States, more cyclical in its biotech part. The positions come from the issuer's publications; performance is calculated on the closing prices of the IYH listing, dividends not reinvested, in the listing currency.

10 first linesweight in the fund

15,75 %
Johnson & JohnsonUS4781601046
9,69 %
AbbVie Inc.US00287Y1091
7,51 %
Merck & Co., Inc.US58933Y1055
5,29 %
3,76 %
Amgen Inc.US0311621009
3,62 %
3,02 %
2,77 %
Pfizer Inc.US7170811035
2,44 %

Sectorsaccording to the issuer

Pharmaceuticals
36,86 %
Biotechnology
23,59 %
Health Care Equipment
15,25 %
Life Sciences Tools & Services
9,98 %
Managed Health Care
7,97 %
Health Care Services
2,47 %
Health Care Facilities
2,15 %
Health Care Supplies
0,78 %
Health Care Technology
0,73 %
Health Care Distributors
0,12 %
Cash and/or Derivatives
0,09 %

Countryaccording to the issuer

United States
99,72 %
United Kingdom
0,28 %

What you need to know

The first 10 lines make up more than half of the fund: it behaves like a basket of a few securities.

Composition: the 50 largest positions

#LineWeightValue
1Eli Lilly and CompanyUS532457108315,75 %744,6 M$
2Johnson & JohnsonUS47816010469,69 %458,5 M$
3AbbVie Inc.US00287Y10917,51 %355,3 M$
4Merck & Co., Inc.US58933Y10555,29 %250,1 M$
5UnitedHealth Group IncorporatedUS91324P10215,18 %245,2 M$
6Thermo Fisher Scientific Inc.US88355610233,76 %177,9 M$
7Amgen Inc.US03116210093,62 %171,2 M$
8Gilead Sciences, Inc.US37555810363,02 %142,8 M$
9Abbott LaboratoriesUS00282410002,77 %131,2 M$
10Pfizer Inc.US71708110352,44 %115,3 M$
11Intuitive Surgical, Inc.US46120E60232,32 %110,0 M$
12Danaher CorporationUS23585110282,12 %100,2 M$
13Vertex Pharmaceuticals IncorporatedUS92532F10032,03 %95,8 M$
14Bristol-Myers Squibb CompanyUS11012210831,85 %87,4 M$
15Medtronic plcIE00BTN1Y1151,82 %86,1 M$
16Stryker CorporationUS86366710131,64 %77,6 M$
17Moderna, Inc.US60770K10791,35 %63,7 M$
18Elevance Health Inc.US03675210381,35 %63,6 M$
19Regeneron Pharmaceuticals, Inc.US75886F10751,31 %61,8 M$
20Cigna CorporationUS12552310031,12 %52,8 M$
21HCA Healthcare, Inc.US40412C10181,05 %49,7 M$
22Boston Scientific CorporationUS10113710770,92 %43,7 M$
23Becton, Dickinson and CompanyUS07588710910,85 %40,1 M$
24Edwards Lifesciences CorporationUS28176E10820,85 %40,1 M$
25IDEXX Laboratories, Inc.US45168D10460,78 %36,8 M$
26Humana Inc.US44485910280,76 %35,9 M$
27Agilent Technologies, Inc.US00846U10160,72 %34,0 M$
28Veeva Systems Inc.US92247510840,66 %31,2 M$
29Waters CorporationUS94184810350,65 %31,0 M$
30IQVIA Holdings Inc.US46266C10530,65 %30,6 M$
31Natera, Inc.US63230710420,62 %29,2 M$
32GE HealthCare Technologies Inc.US36266G10760,54 %25,8 M$
33Revolution Medicines, Inc.US76155X10000,54 %25,4 M$
34Biogen Inc.US09062X10370,53 %25,2 M$
35Centene CorporationUS15135B10170,50 %23,7 M$
36ResMed Inc.US76115210780,50 %23,5 M$
37Zoetis Inc.US98978V10350,49 %23,0 M$
38Illumina, Inc.US45232710900,47 %22,3 M$
39Labcorp Holdings Inc.US50492210550,44 %20,7 M$
40DexCom, Inc.US25213110740,43 %20,5 M$
41Quest Diagnostics IncorporatedUS74834L10080,41 %19,4 M$
42West Pharmaceutical Services, Inc.US95530610550,41 %19,3 M$
43Royalty Pharma plcGB00BMVP7Y090,41 %19,2 M$
44STERIS plcIE00BFY8C7540,36 %17,0 M$
45Insmed IncorporatedUS45766930750,36 %16,9 M$
46United Therapeutics CorporationUS91307C10270,34 %16,0 M$
47Viatris Inc.US92556V10610,34 %15,9 M$
48Tenet Healthcare CorporationUS88033G40730,33 %15,6 M$
49Alnylam Pharmaceuticals, Inc.US02043Q10760,30 %14,3 M$
50Zimmer Biomet Holdings, Inc.US98956P10210,30 %14,1 M$

Comparable ETFs

The overlap measures the part of the portfolio common to both funds (sum of minimum weights on shared lines): beyond 70 %, holding both provides almost no diversification.

ETFFeesOutstandingPerf. 1 yearRecovery
iShares S&P 500 Health Care Sector UCITS ETFQDVG.DE · IShares0,15 %3,58 $bn+30,5 %91,7 %compare
State Street Health Care Select Sector SPDR ETFXLV · SPDR0,08 %49,69 $bn+23,6 %91,6 %compare
Fidelity MSCI Health Care Index ETFFHLC · Fidelity0,08 %3,95 $bn+23,1 %88,5 %compare
Vanguard Health Care ETFVHT · Vanguard0,09 %19,10 $bn+22,6 %87,0 %compare
iShares Global Healthcare ETFIXJ · IShares0,38 %4,64 $bn+19,3 %68,8 %compare
Xtrackers MSCI World Health Care UCITS ETF 1CXDWH.DE · Xtrackers0,25 %4,61 $bn+24,6 %68,8 %compare
GMO US Quality ETFQLTY · GMO0,50 %5,40 $bn+18,8 %23,2 %compare
iShares Future Exponential Technologies ETFXT · IShares0,46 %3,81 $bn+11,5 %22,0 %compare

Its holdings in other ETFsdouble exposure

The top holdings of IYH are found in many other funds: combining several ETFs often means holding the same companies multiple times.

  • Eli Lilly and Company : 15,75 % in this fund; held by 1 003 ETF, 204,86 Bn$ in total
  • Johnson & Johnson : 9,69 % in this fund; held by 942 ETF, 121,50 Bn$ in total
  • AbbVie Inc. : 7,51 % in this fund; held by 931 ETF, 89,91 Bn$ in total
  • Merck & Co., Inc. : 5,29 % in this fund; held by 959 ETF, 73,55 Bn$ in total
  • UnitedHealth Group Incorporated : 5,18 % in this fund; held by 853 ETF, 72,16 Bn$ in total
  • Thermo Fisher Scientific Inc. : 3,76 % in this fund; held by 663 ETF, 41,62 Bn$ in total
  • Amgen Inc. : 3,62 % in this fund; held by 902 ETF, 62,68 Bn$ in total
  • Gilead Sciences, Inc. : 3,02 % in this fund; held by 939 ETF, 48,22 Bn$ in total

Information provided for educational purposes from the positions published by the issuers and closing prices. Past performance is not indicative of future performance; fees and assets under management are those declared by the source and may contain errors. Investing involves a risk of capital loss.

Frequently Asked Questions

To understand well

What are the fees of the IYH ETF?
Reported ongoing fees are 0,37 % per year. Fees of 0,37 % per year represent 37 € collected each year for every 10 000 € invested, directly in the share value.
What are the largest holdings of iShares U.S. Healthcare ETF?
The first ten lines weigh 59,0 % of the fund: Eli Lilly and Company (15,8 %), Johnson & Johnson (9,7 %), AbbVie Inc. (7,5 %), Merck & Co., Inc. (5,3 %), UnitedHealth Group Incorporated (5,2 %).
Is the IYH ETF eligible for a PEA?
No: the fund is domiciled outside the European Economic Area (ISIN US4642877629), it cannot be held in a PEA. It remains accessible in a securities account.
What is the performance of IYH over 5 years?
+36,7 % over 5 years, i.e., +6,5 % per year, in USD and dividends not reinvested (closing price at 2026-11-13).

← All ETF tools